CXC receptor-2 knockout genotype increases X-linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicity

Hepatology

Volumn 52, Issue 2, 2010, Pages 691-702

  Hu, Bin ^a   Colletti, Lisa M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 9; CHEMOKINE RECEPTOR CXCR2; PARACETAMOL; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENOTYPE; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; WESTERN BLOTTING;

ACETAMINOPHEN; ANIMALS; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION; GENOTYPE; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-8B; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77955680476     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23715     Document Type: Article

References (22)

1. Sakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis and applicability of prognostic criteria. Liver Transpl 2000;6:163-169.
2. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-Acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A 1984;81:1327-1331.
3. Levkau B, Garton KJ, Ferri N, Kloke K, Nofer JR, Baba HA, et al. xIAP induces cell-cycle arrest and activates nuclear factor-κB. New survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ Res 2001;88:282-290.
4. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor or apoptosis, c-IAP is under NF-KB control. Proc Nat Acad Sci U S A 1997;94:10057-10062.
5. Bone-Larson CL, Hogaboam CM, Evanhoff H, Strieter RM, Kunkel SL. IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury though induction of CXCR2 on hepatocytes. J Immunol 2001;167:7077-7083.
6. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Lukas NW, Colletti LM, Simpson KJ, et al. Novel CXCR2-dependent liver regenerative qualities of ELR containing CXC chemokines. FASEB J 1999;13:1565-1574.
7. Ren X, Carpenter A, Hogaboam C, Colletti L. Mitogenic properties of endogenous and pharmacologic doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol 2003;163:563-570.
8. Stefanovic L, Brenner DA, Stefanovic B. Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med 2005;230:573-586.
9. Kofman AV, Morgan G, Kirschenbaum A, Osbeck J, Hussain M, Swenson S, et al. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. HEPATOLOGY 2005;41:1252-1261.
10. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 2003;8:345-352.
11. Wietek C, Cleaver CS, Ludbrook V, Wilde J, White J, Bell DJ, et al. IkappaB kinase epsilon interacts with p52 and promotes transactivation via p65. J Biol Chem 2006;281:34973-34981.
12. Xiao G, Rabson AB, Young W, Qing G, Qu Z. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006;17:281-293.
13. Kuboki S, Shin T, Huber N, Eismann T, Galloway E, Schuster R, et al. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. HEPATOLOGY 2008;48:1213-1223.
14. Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N. Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 2006;36:1028-1038.
15. Deverauz QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-2223.
16. Nadiminty N, Chun JY, Lou W, Lin X, Gao AC. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. Prostate 2008;68:1725-1733.
17. Lwin T, Hazlehurst LA, Li Z, Dessureault S, Sotomayor E, Moscinski LC, et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB(RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia 2007;21:1521-1531.
18. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-KB and JNK. An intricate affair. Cell Cycle 2004;3:1524-1529.
19. Latchoumycandane C, Goh CW, Ong MMK, Boelsterli UA. Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. HEPATOLOGY 2007;45:412-421.
20. Kaur S, Wang F, Venkatraman M, Arsura M. X-linked inhibitor of apoptosis (XIAP) inhibits c-jun-N-terminal kinase 1 (JNK1) activation by transforming growth factor β1 (TGF-β1) through ubiquitin-mediated proteosomal degradation of the TGF-β1-activated kinase 1 (TAK1). J Biol Chem 2005;280:38599-38608.
21. Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006;131:165-178.
22. Hanawa H, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz H. Role of JNK translocation to mitochondria leading to inhibition of mitochondrial bioenergetics in acetaminophen-induced liver injury. J Biol Chem 2008;283:13565-13577.